静息态人脑觉醒的全基因组关联研究
该研究在基于人群的 LIFE-Adult 队列中选取 1877 名参与者,进行 20 分钟闭眼静息态脑电并使用 VIGALL 2.1 分析觉醒水平,开展全基因组关联研究(GWAS)。SNP 水平未发现全基因组显著位点(p < 5E-8),但七个位点提示关联(p < 1E-6),最强信号为 TMEM159 的 eQTL(lead-SNP rs79472635,p = 5.49E-8);基因水平 TMEM159 显著(p = 0.013,Bonferroni 校正)。TMEM159 对应标记与重性抑郁障碍(MDD)呈名义显著关联(0.006 ≤ p ≤ 0.011),高觉醒相关变异此前与 MDD 风险增加相关;通路分析提示钠/钙交换体在静息态觉醒中起作用。
要点
- 静息态脑电觉醒水平的 GWAS 未检出全基因组显著 SNP 位点。
- TMEM159 在基因水平与静息态觉醒显著关联,为 novel 候选基因。
- TMEM159 变异与 MDD 名义关联,高觉醒变异与 MDD 风险增加相关。
核心结论
- 本 GWAS 识别 TMEM159 为可能通过觉醒机制调节精神障碍风险的新候选基因。
- 结果支持离子通道调节剂、睡眠-觉醒行为与精神障碍之间关联的进一步研究。
研究设计与样本
- 从基于人群的 LIFE-Adult 队列选取 N = 1877 名参与者。
- 参与者接受 20 分钟闭眼静息态脑电,使用 VIGALL 2.1 分析觉醒水平。
- 开展全基因组关联研究(GWAS),并进行基因水平、通路及与 PGC 结果的映射分析。
主要发现
- SNP 水平 GWAS 未发现全基因组显著位点(p < 5E-8),七个位点提示关联(p < 1E-6)。
- 最强命中为 TMEM159 的 eQTL(lead-SNP rs79472635,p = 5.49E-8)。
- 基因水平 GWAS 显示 TMEM159 显著(p = 0.013,Bonferroni 校正)。
- TMEM159 对应标记与 MDD 呈名义显著关联(0.006 ≤ p ≤ 0.011),高觉醒相关变异此前与 MDD 风险增加相关。
- 通路分析提示钠/钙交换体在静息态觉醒中起作用。
关键数值与推荐
- 全基因组显著性阈值 p < 5E-8,提示性阈值 p < 1E-6。
- TMEM159 lead-SNP rs79472635 的 p = 5.49E-8。
- TMEM159 基因水平 p = 0.013(Bonferroni 校正)。
- TMEM159 标记与 MDD 关联的 p 值范围为 0.006 ≤ p ≤ 0.011。
临床怎么用
- 静息态脑电觉醒水平可作为研究精神障碍遗传机制的中间表型。
- TMEM159 及钠/钙交换体通路值得在精神障碍风险分层中进一步验证。
- 高觉醒相关遗传变异可能提示 MDD 风险增加,需结合临床评估。
局限性
- SNP 水平未达全基因组显著性,最强信号仅为提示性关联。
- TMEM159 与 MDD 的关联仅为名义显著,需独立样本验证。
- 样本来自单一队列,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Arousal affects cognition, emotion, and behavior and has been implicated in the etiology of psychiatric disorders. Although environmental conditions substantially contribute to the level of arousal, stable interindividual characteristics are well-established and a genetic basis has been suggested. Here we investigated the molecular genetics of brain arousal in the resting state by conducting a genome-wide association study (GWAS). We selected N = 1877 participants from the population-based LIFE-Adult cohort. Participants underwent a 20-min eyes-closed resting state EEG, which was analyzed using the computerized VIGALL 2.1 (Vigilance Algorithm Leipzig). At the SNP-level, GWAS analyses revealed no genome-wide significant locus (p < 5E-8), although seven loci were suggestive (p < 1E-6). The strongest hit was an expression quantitative trait locus (eQTL) of TMEM159 (lead-SNP: rs79472635, p = 5.49E-8). Importantly, at the gene-level, GWAS analyses revealed significant evidence for TMEM159 (p = 0.013, Bonferroni-corrected). By mapping our SNPs to the GWAS results from the Psychiatric Genomics Consortium, we found that all corresponding markers of TMEM159 showed nominally significant associations with Major Depressive Disorder (MDD; 0.006 ≤ p ≤ 0.011). More specifically, variants associated with high arousal levels have previously been linked to an increased risk for MDD. In line with this, the MetaXcan database suggests increased expression levels of TMEM159 in MDD, as well as Autism Spectrum Disorder, and Alzheimer's Disease. Furthermore, our pathway analyses provided evidence for a role of sodium/calcium exchangers in resting state arousal. In conclusion, the present GWAS identifies TMEM159 as a novel candidate gene which may modulate the risk for psychiatric disorders through arousal mechanisms. Our results also encourage the elaboration of the previously reported interrelations between ion-channel modulators, sleep-wake behavior, and psychiatric disorders.
引用
- Jawinski P, Kirsten H, Sander C, et al. Human brain arousal in the resting state: a genome-wide association study. Mol Psychiatry. 2018. PMID: 29703947. doi:10.1038/s41380-018-0052-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。